drugset / Trial / NCT02919072

Chloroprocaine 3% - Epidural Anesthesia in Unplanned Caesarean Section

NCT02919072

Phase 3 Terminated 16 enrolled Sintetica SA Cross Research S.A. · collab
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The study evaluate the quality of epidural anaesthesia and the safety of Chloroprocaine HCl 3% compared with Ropivacaine HCl 0.75% in patients with an epidural catheter in situ undergoing unplanned Caesarean section.

Timeline

Start
2016-10
Primary completion
2021-06
Completion
2021-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Chloroprocaine Other / unclassified 20 ml Other
Comparator Ropivacaine Other / unclassified 20 ml Other

Indications

No indication recorded.